Aug 25, 2026 07:05AM
Aug 25, 2026 07:00AM
Aug 25, 2026 07:00AM
Jul 13, 2026 02:01AM
Jul 13, 2026 02:00AM
Jul 13, 2026 02:00AM
Jul 13, 2026 02:00AM PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Jul 2, 2026 02:01AM
Jul 2, 2026 02:01AM
Jun 9, 2026 02:00AM
Jun 9, 2026 02:00AM
May 13, 2026 07:00AM
Apr 29, 2026 02:01AM
Apr 22, 2026 07:00AM PureTech reports positive data from cancer drug trial
Apr 22, 2026 07:00AM
Apr 2, 2026 08:19AM
Apr 2, 2026 08:19AM
Feb 19, 2026 12:37PM
Feb 19, 2026 12:36PM
Dec 8, 2025 02:00AM
Dec 8, 2025 02:00AM PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
Oct 22, 2025 04:44AM
Oct 22, 2025 02:00AM
Sep 29, 2025 02:00AM
Aug 21, 2025 07:01AM
Aug 21, 2025 07:00AM
Aug 12, 2025 07:01AM
Aug 12, 2025 07:00AM PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases
May 9, 2025 07:00AM
May 1, 2025 07:00AM
Dec 16, 2024 02:00AM
Oct 9, 2024 02:00AM
Oct 1, 2024 07:00AM
Aug 28, 2024 02:01AM
Apr 25, 2024 05:22AM PureTech Announces Annual Results for Year Ended December 31, 2023
Apr 16, 2024 07:00AM
Oct 11, 2023 07:00AM
Aug 29, 2023 02:00AM
Aug 1, 2023 07:01AM
Aug 1, 2023 07:00AM
Apr 28, 2023 02:00AM
Mar 23, 2023 03:00AM PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million
Dec 22, 2022 05:24AM
Dec 22, 2022 02:00AM
Aug 1, 2022 07:05AM
Aug 1, 2022 07:05AM
Jul 11, 2022 07:05AM
Jun 30, 2022 07:00AM
Apr 12, 2022 07:06AM PureTech Health-Founded (PRTC) Akili Interactive Reports Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Co
Apr 12, 2022 07:05AM

68,105 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All